Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PACS Stock Forecast 2025-2026
$31.12
Current Price
$4.87B
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PACS Price Targets
+28.5%
To High Target of $40.00
+6.0%
To Median Target of $33.00
+2.8%
To Low Target of $32.00
PACS Price Momentum
-1.2%
1 Week Change
+152.8%
1 Month Change
+105.8%
1 Year Change
+137.4%
Year-to-Date Change
-11.3%
From 52W High of $35.10
+314.9%
From 52W Low of $7.50
📊 TOP ANALYST CALLS
Did PACS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if PACS Group is one of their latest high-conviction picks.
Latest PACS Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, PACS has a bullish consensus with a median price target of $33.00 (ranging from $32.00 to $40.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $31.12, the median forecast implies a 6.0% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Lisa Gill at JP Morgan, projecting a 28.5% upside. Conversely, the most conservative target is provided by David Macdonald at Truist Securities, suggesting a 2.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PACS Analyst Ratings
2
Buy
0
Hold
0
Sell
PACS Price Target Range
Low
$32.00
Average
$33.00
High
$40.00
Current: $31.12
Latest PACS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PACS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 20, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $33.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $32.00 |
| Jan 6, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $24.00 |
| Dec 17, 2024 | JP Morgan | Neutral | Downgrade | $N/A | |
| Nov 18, 2024 | Stephens & Co. | Scott Fidel | Overweight | Maintains | $31.00 |
| Nov 6, 2024 | JP Morgan | Lisa Gill | Overweight | Reinstates | $40.00 |
| Oct 14, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $46.00 |
| Oct 9, 2024 | UBS | A.J. Rice | Buy | Initiates | $50.00 |
| Sep 11, 2024 | Citigroup | Jason Cassorla | Buy | Reinstates | $45.00 |
| Aug 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $44.00 |
| Aug 13, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $40.00 |
| Aug 13, 2024 | Stephens & Co. | Scott Fidel | Overweight | Maintains | $40.00 |
| Aug 13, 2024 | Citigroup | Jason Cassorla | Buy | Maintains | $41.00 |
| Jul 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $36.00 |
| Jun 28, 2024 | Macquarie | Tao Qiu | Outperform | Initiates | $35.00 |
| May 15, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $32.00 |
| May 15, 2024 | RBC Capital | Ben Hendrix | Outperform | Maintains | $32.00 |
| May 15, 2024 | Truist Securities | David Macdonald | Buy | Maintains | $32.00 |
| May 14, 2024 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $31.00 |
| May 6, 2024 | Oppenheimer | Michael Wiederhorn | Outperform | Initiates | $31.00 |
Pacs Group Inc. (PACS) Competitors
The following stocks are similar to PACS Group based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Pacs Group Inc. (PACS) Financial Data
Pacs Group Inc. has a market capitalization of $4.87B with a P/E ratio of 29.6x. The company generates $5.14B in trailing twelve-month revenue with a 3.3% profit margin.
Revenue growth is +31.0% quarter-over-quarter, while maintaining an operating margin of +6.4% and return on equity of +21.7%.
Valuation Metrics
Market Cap
$4.87B
Enterprise Value
$8.18B
P/E Ratio
29.6x
PEG Ratio
-0.1x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+31.0%
Gross Margin
+15.1%
Operating Margin
+6.4%
Net Margin
+3.3%
EPS Growth
+235.5%
Financial Health
Cash/Price Ratio
+7.3%
Current Ratio
0.9x
Debt/Equity
416.7x
ROE
+21.7%
ROA
+3.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Pacs Group Inc. (PACS) Business Model
About Pacs Group Inc.
What They Do
Provides integrated packaging solutions globally.
Business Model
The company generates revenue by producing and selling innovative and sustainable packaging materials to various industries, including food, personal care, pharmaceuticals, and industrial goods. By leveraging cutting-edge technology and eco-friendly practices, it meets the increasing demand for sustainable packaging solutions.
Additional Information
Pacs Group Inc. emphasizes research and development to create packaging that minimizes environmental impact while ensuring product integrity. Collaborating with major manufacturers and retailers, it enhances its role in the global supply chain, focusing on safety and aesthetics in packaging design.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
45,680
CEO
Mr. Jason Murray
Country
United States
IPO Year
N/A
Website
pacs.comPacs Group Inc. (PACS) Latest News & Analysis
Latest News
Quick Summary
Evelyn Dilsaver, a board member of PACS Group, purchased $500,000 in PACS Group stock.
Why It Matters
Evelyn Dilsaver's $500,000 stock purchase signals confidence in PACS Group's future, potentially influencing investor sentiment and stock performance.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
PACS Group, Inc. (NYSE: PACS) appointed Kelly Priegnitz as Chief Compliance Officer and Trent Bingham as Chief Human Resources Officer, effective December 1 and November 10, respectively.
Why It Matters
Leadership changes at PACS Group, Inc. could signal strategic shifts and impact operational effectiveness, influencing investor confidence and stock performance in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
PACS Group Announces Business Updates
10 days ago
Quick Summary
PACS Group, Inc. (NYSE: PACS) reported strong year-to-date performance and announced updates, including an amendment to its credit agreement and expansion of its portfolio.
Why It Matters
PACS Group's strong performance and credit agreement amendment indicate financial stability and growth potential, likely enhancing investor confidence and stock value.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Markets declined on Thursday, reversing early gains amid concerns following Nvidia's financial results. PACS Group and Exact Sciences were notable gainers.
Why It Matters
Broad market decline signals investor uncertainty, overshadowing Nvidia's results. Gains in PACS Group and Exact Sciences suggest sector-specific opportunities amid overall market volatility.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
PACS Group, Inc. will hold its Q3 2025 earnings call on November 19, 2025, featuring CEO Jason Murray and other executives. Analysts from Truist, JPMorgan, and RBC will participate.
Why It Matters
PACS Group's Q3 earnings call indicates upcoming financial insights, which can influence stock performance and investor sentiment based on revenue and profit trends discussed.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
PACS has reported its third-quarter 2025 operating results and has completed its financial restatement, now in compliance with SEC requirements.
Why It Matters
PACS’s restated financials and compliance with SEC obligations suggest improved transparency and stability, potentially boosting investor confidence and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About PACS Stock
What is Pacs Group Inc.'s (PACS) stock forecast for 2026?
Based on our analysis of 10 Wall Street analysts, Pacs Group Inc. (PACS) has a median price target of $33.00. The highest price target is $40.00 and the lowest is $32.00.
Is PACS stock a good investment in 2026?
According to current analyst ratings, PACS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $31.12. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PACS stock?
Wall Street analysts predict PACS stock could reach $33.00 in the next 12 months. This represents a 6.0% increase from the current price of $31.12. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Pacs Group Inc.'s business model?
The company generates revenue by producing and selling innovative and sustainable packaging materials to various industries, including food, personal care, pharmaceuticals, and industrial goods. By leveraging cutting-edge technology and eco-friendly practices, it meets the increasing demand for sustainable packaging solutions.
What is the highest forecasted price for PACS Pacs Group Inc.?
The highest price target for PACS is $40.00 from Lisa Gill at JP Morgan, which represents a 28.5% increase from the current price of $31.12.
What is the lowest forecasted price for PACS Pacs Group Inc.?
The lowest price target for PACS is $32.00 from David Macdonald at Truist Securities, which represents a 2.8% increase from the current price of $31.12.
What is the overall PACS consensus from analysts for Pacs Group Inc.?
The overall analyst consensus for PACS is bullish. Out of 10 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $33.00.
How accurate are PACS stock price projections?
Stock price projections, including those for Pacs Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 11, 2025 3:15 PM UTC